ArticleFrontiers in global women's health2026
PDGF-BB as a potential biomarker for early diagnosis of postpartum hemorrhage.
Article in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
Abstract
Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality, highlighting the need for effective methods to detect early identification and intervention. Previous data demonstrates that endothelial cilia, a microtubule-based organelle is responsible for vascular stability. Thus, we rationalized that proteins inside endothelial cilia may be candidates for conditions affected by dysregulated flow and barrier formation. Protein expression of four ciliary-associated candidates, including Platelet-Derived Growth Factor-BB (PDGF-BB), were quantified using Western blot and enzyme-linked immunosorbent assay (ELISA). Baseline characteristics were compared across groups, and logistic regression and receiver operating characteristic (ROC) analyses were performed to evaluate the association between PDGF-BB levels and PPH risk. Baseline characteristics were comparable across groups, except for maternal race and pre-pregnancy body mass index. Among the proteins evaluated, PDGF-BB demonstrated consistent differential expression across both analytical platforms. Higher PDGF-BB levels were independently associated with a lower risk of PPH in both unadjusted and adjusted models (adjusted OR 0.62, 95% CI 0.44-0.88;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.